BlackRock Health Sciences Term Trust (NYSE:BMEZ) Announces Monthly Dividend of $0.11

BlackRock Health Sciences Term Trust (NYSE:BMEZ) announced a monthly dividend on Friday, December 12th. Investors of record on Monday, December 22nd will be given a dividend of 0.11 per share on Wednesday, December 31st. This represents a c) annualized dividend and a dividend yield of 8.7%. The ex-dividend date is Monday, December 22nd.

BlackRock Health Sciences Term Trust Price Performance

BlackRock Health Sciences Term Trust stock opened at $15.18 on Friday. BlackRock Health Sciences Term Trust has a one year low of $12.58 and a one year high of $16.75. The company’s fifty day moving average price is $15.04 and its two-hundred day moving average price is $14.57.

Institutional Investors Weigh In On BlackRock Health Sciences Term Trust

Large investors have recently added to or reduced their stakes in the stock. Allworth Financial LP grew its holdings in BlackRock Health Sciences Term Trust by 24,584.6% during the third quarter. Allworth Financial LP now owns 3,209 shares of the company’s stock valued at $46,000 after purchasing an additional 3,196 shares during the last quarter. NewEdge Advisors LLC raised its holdings in BlackRock Health Sciences Term Trust by 17.9% in the 3rd quarter. NewEdge Advisors LLC now owns 56,941 shares of the company’s stock worth $821,000 after acquiring an additional 8,641 shares during the period. Susquehanna International Group LLP bought a new stake in BlackRock Health Sciences Term Trust during the third quarter valued at about $1,097,000. City of London Investment Management Co. Ltd. acquired a new stake in shares of BlackRock Health Sciences Term Trust in the third quarter valued at about $1,068,000. Finally, Bank of America Corp DE increased its stake in shares of BlackRock Health Sciences Term Trust by 4.1% in the third quarter. Bank of America Corp DE now owns 1,535,091 shares of the company’s stock worth $22,136,000 after purchasing an additional 61,105 shares during the period.

About BlackRock Health Sciences Term Trust

BlackRock Health Sciences Term Trust (NYSE: BMEZ) is a closed-end management investment company organized as a Delaware statutory trust. Launched in March 2020, BMEZ seeks to provide total return through a combination of current income and capital appreciation by investing primarily in equity and equity-related securities of companies in the health sciences sector. The trust is structured with a fixed termination date in October 2030, at which time shareholders will vote on its liquidation, extension or conversion.

The fund’s investment portfolio is diversified across subsectors within health sciences, including biotechnology, pharmaceuticals, medical devices, diagnostics and healthcare services.